Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
Condition(s):Vasomotor SymptomsLast Updated:February 8, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Vasomotor SymptomsLast Updated:February 8, 2023Recruiting
Condition(s):Overactive Bladder Syndrome; Neuropathic BladderLast Updated:August 22, 2023Recruiting
Condition(s):Hyperhidrosis; Oxybutynin; Sweat Gland Diseases; Skin Diseases; Autonomic Agents; Cholinergic Antagonists; ParasympatholyticsLast Updated:November 1, 2021Unknown status
Condition(s):HyperhidrosisLast Updated:September 22, 2011Completed
Condition(s):HyperhidrosisLast Updated:July 8, 2014Completed
Condition(s):Nocturnal EnuresisLast Updated:September 2, 2015Completed
Condition(s):Spinal Cord Injuries; Urinary Bladder, NeurogenicLast Updated:December 17, 2019Unknown status
Condition(s):Obstructive Sleep Apnea (OSA)Last Updated:January 29, 2019Completed
Condition(s):HyperhidrosisLast Updated:June 19, 2018Completed
Condition(s):HyperhidrosisLast Updated:April 4, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.